Latest Breaking News On - Sepideh besharati - Page 1 : comparemela.com

Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical trial led by researchers

United statesUniversity of southern californiaMolly geareDavid limElizabethm jaffeeChenguang wangAshley cimino mathewsLos angelesRoisinm connollyMichellea rudekRoussos torresLeslie anforthJohns hopkinsRoberta andersEvanthiat roussos torresQingfeng zhu